Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Breaking Dual Habits: Anxiety Sensitivity in Smoking and Cannabis Cessation
This study is important because it looks at how to help people who use both cigarettes and cannabis to quit. They found that a special kind of program, targeting something called “anxiety sensitivity,” helped people stop smoking for a longer time.
Legislation and Regulation for the New Year and a Look Ahead
Legislative changes go into effect across the country. The DEA asserts its authority on rescheduling marijuana and reports a significant increase in clinical trials using hallucinogenic substances. Johns Hopkins begins landmark research on marijuana. A look ahead at what 2024 may hold for cannabis.
Unveiling the Cognitive Impact of Prescribed Medical Cannabis
This study explores the impact of prescribed medical cannabis on cognitive function in 40 participants with various health conditions, revealing modest overall effects despite improvements in specific cognitive tests.
Uncertainty in many states, healthy consumption, and marijuana use makes people nicer.
States grapple with judicial, regulatory and legislative uncertainty. Advice on healthy consumption, increased use among seniors, and it turns out marijuana consumers are nicer people.
Unveiling the Link Between Marijuana and COVID-19: A Surprising Revelation
Amid the ongoing COVID-19 pandemic, a recent study has brought forth unexpected insights into the interplay between marijuana use and outcomes for those infected with the virus. With marijuana use on the rise globally, the study addresses a significant gap in our understanding of its effects on health. Specifically, it seeks to compare the outcomes of COVID-19 infection in individuals who use marijuana against those who do not, probing whether marijuana use could influence the course of the disease.
Legalization in the East, West, and Center of the Country. Occupational Risks, Lab Testing, and Teen Use.
California, New Hampshire, New York, and Wisconsin face different aspects of legalization. Teen usage doesn’t change following legalization. On the production side, the lab testing problems and the CDC identifies potential occupational risks in manufacturing.
A Nuanced Exploration into Cannabis and Human Health
The comprehensive findings from this review paper serve as a valuable resource for informing public health policies and guidelines related to the use of cannabis, cannabinoids, and cannabis-based medicines.
Ohio Votes for Legalization. Cannabis as an Alternative for Pain Relief and Sleep.
The big news this week is Ohio’s vote to legalize marijuana. A round from The Hill on what is and isn’t legal. A few interesting studies this about marijuana and CBD as an alternative to opioids and sleep aids.
Unlocking the Potential of CBD for Hypertension: A Promising Breakthrough in a Double-Blind Study
This study explores the potential benefits of DehydraTECH™2.0 CBD, a novel CBD delivery system, and its effects on blood pressure, considering genetic factors, with implications for optimizing CBD formulations and enhancing its therapeutic potential in various disorders.
Respondents Embrace Cannabis with Medical Oversight, Exotic Cannabis Compounds, and a Look at the New Speaker’s Voting Record
Interesting research out this week showed a high percentage of respondents are willing to use medicinal cannabis under a physician’s care and that they are interested in having cannabis care included in the healthcare coverage. A study out this week identified additional compounds in cannabis terpenes. In California, Maine, Massachusetts, and Nevada traffic fatalities are down following legalization. A brief overview of the new Speaker of the House’s voting record on cannabis. And further north Health Canada predicts a continuing increase in cannabis exports.